Patents by Inventor David William Fennelly

David William Fennelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy method for treating breast cancer using edatrexate
    Patent number: 6262054
    Abstract: This invention provides combination therapy methods, pharmaceutical combinations and compositions for inducing tumor cell regression in cancer patients, particularly metastatic breast cancer patients. The combination methods, combinations and compositions employ both edatrexate and a taxane which are administered simultaneously or sequentially. The combination therapy described here permits the administration of unusually high doses of edatrexate.
    Type: Grant
    Filed: February 1, 1996
    Date of Patent: July 17, 2001
    Assignee: Sloan-Kettering Institute of Cancer Research
    Inventors: David William Fennelly, Francis Michael Sirotnak